Search research articles
Contact Us
Filters
Showing results (121-130 of 136) with videos related to
Page
of 14
Sort By:
Clinical and Translational Radiation Oncology
|
December 15, 2020
Marker-less online MR-guided stereotactic body radiotherapy of liver metastases at a 1.5 T MR-Linac - Feasibility, workflow data and patient acceptance
Cihan Gani, S Boeke, H McNair, et al.
Gene Therapy
|
January 16, 2004
Reduced toxicity of F-deficient Sendai virus vector in the mouse fetus
S N Waddington, S M K Buckley, C Bernloehr, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 3, 2004
Rituximab consolidation after high-dose chemotherapy and autologous blood stem cell transplantation in follicular and mantle cell lymphoma: a prospective, multicenter phase II study
W Brugger, J Hirsch, F Grünebach, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))
|
June 29, 2016
A Consensus German Reporting Standard for Secondary Data Analyses, Version 2 (STROSA-STandardisierte BerichtsROutine für SekundärdatenAnalysen)
E Swart, E M Bitzer, H Gothe, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))
|
July 19, 2016
[A Consensus German Reporting Standard for Secondary Data Analyses, Version 2 (STROSA-STandardisierte BerichtsROutine für SekundärdatenAnalysen)]
E Swart, E M Bitzer, H Gothe, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 5, 2020
CONKO-006: A randomised double-blinded phase IIb-study of additive therapy with gemcitabine + sorafenib/placebo in patients with R1 resection of pancreatic cancer - Final results
M Sinn, T Liersch, H Riess, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 11, 2018
Neoadjuvant chemotherapy followed by chemoradiation and surgery with and without cetuximab in patients with resectable esophageal cancer: a randomized, open-label, phase III trial (SAKK 75/08)
T Ruhstaller, P Thuss-Patience, S Hayoz, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
TROPHIT1-a randomized, open-label, multicenter, phase II/III trial of sacituzumab govitecan compared to standard of care in metastatic colorectal cancer patients
B C Köhler, G M Haag, L Le Cornet, et al.
ESMO Open
|
November 22, 2021
Rationale and design of the CRAFT (Continuous ReAssessment with Flexible ExTension in Rare Malignancies) multicenter phase II trial
C E Heilig, P Horak, S Kreutzfeldt, et al.
Molecular Imaging and Biology
|
October 4, 2017
Combined PET/MRI: Global Warming-Summary Report of the 6th International Workshop on PET/MRI, March 27-29, 2017, Tübingen, Germany
D L Bailey, B J Pichler, B Gückel, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 136) with videos related to
Sort By:
Page
of 14
Clinical and Translational Radiation Oncology
|
December 15, 2020
Marker-less online MR-guided stereotactic body radiotherapy of liver metastases at a 1.5 T MR-Linac - Feasibility, workflow data and patient acceptance
Cihan Gani, S Boeke, H McNair, et al.
Gene Therapy
|
January 16, 2004
Reduced toxicity of F-deficient Sendai virus vector in the mouse fetus
S N Waddington, S M K Buckley, C Bernloehr, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 3, 2004
Rituximab consolidation after high-dose chemotherapy and autologous blood stem cell transplantation in follicular and mantle cell lymphoma: a prospective, multicenter phase II study
W Brugger, J Hirsch, F Grünebach, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))
|
June 29, 2016
A Consensus German Reporting Standard for Secondary Data Analyses, Version 2 (STROSA-STandardisierte BerichtsROutine für SekundärdatenAnalysen)
E Swart, E M Bitzer, H Gothe, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))
|
July 19, 2016
[A Consensus German Reporting Standard for Secondary Data Analyses, Version 2 (STROSA-STandardisierte BerichtsROutine für SekundärdatenAnalysen)]
E Swart, E M Bitzer, H Gothe, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 5, 2020
CONKO-006: A randomised double-blinded phase IIb-study of additive therapy with gemcitabine + sorafenib/placebo in patients with R1 resection of pancreatic cancer - Final results
M Sinn, T Liersch, H Riess, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 11, 2018
Neoadjuvant chemotherapy followed by chemoradiation and surgery with and without cetuximab in patients with resectable esophageal cancer: a randomized, open-label, phase III trial (SAKK 75/08)
T Ruhstaller, P Thuss-Patience, S Hayoz, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
TROPHIT1-a randomized, open-label, multicenter, phase II/III trial of sacituzumab govitecan compared to standard of care in metastatic colorectal cancer patients
B C Köhler, G M Haag, L Le Cornet, et al.
ESMO Open
|
November 22, 2021
Rationale and design of the CRAFT (Continuous ReAssessment with Flexible ExTension in Rare Malignancies) multicenter phase II trial
C E Heilig, P Horak, S Kreutzfeldt, et al.
Molecular Imaging and Biology
|
October 4, 2017
Combined PET/MRI: Global Warming-Summary Report of the 6th International Workshop on PET/MRI, March 27-29, 2017, Tübingen, Germany
D L Bailey, B J Pichler, B Gückel, et al.
Page
of 14